Download presentation
Presentation is loading. Please wait.
Published byLeony Sutedja Modified over 5 years ago
1
Cell Saver for On-pump Coronary Operations Reduces Systemic Inflammatory Markers: A Randomized Trial
Sune Damgaard, MD, PhD, Claus H. Nielsen, MD, PhD, Lars W. Andersen, MD, DMSc, Klaus Bendtzen, MD, DMSc, Michael Tvede, MD, Daniel A. Steinbrüchel, MD, DMSc The Annals of Thoracic Surgery Volume 89, Issue 5, Pages (May 2010) DOI: /j.athoracsur Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 The graph shows, only for the 15 cell saver patients before and after cell saving, the relative changes of certain inflammatory markers in the (A) suction blood and in the residual blood from the (B) cardiopulmonary bypass (CPB) circuit before retransfusion. Columns are median percentage changes with quartiles. All changes were statistically significant (p < 0.05) except for procalcitonin (PCT) in the CPB blood (p = 0.279). There was an increase in interleukin (IL)-8 in the CPB blood after cell saver processing (p = 0.031). (sTNF-RI and -RII = soluble tumor necrosis factor receptor I and II.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.